Following requests from the US Food and Drug Administration for additional emergency funding of $275.0 million to allow the agency to carry out some of its oversight duties with respect to medicinal and food products (Marketletter June 9), Health and Human Services Secretary Michael Leavitt has announced that the Administration is amending its budget request for the fiscal year 2009 to include this additional amount for the FDA.
This request comes against a background of severe criticism of the agency in terms of its failure in preventing the import of fake and sub-standard drugs, including the heparin fiasco, as well as contaminated food products (Marketletters passim).
Mr Leavitt called on Congress to move swiftly on this budget amendment and pending Administration legislative proposals to strengthen the FDA. If approved, the funding would be supplemental to the agency's proposed 2009 budget of $2.4 billion.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze